Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease.

anticancer drug diagnosis drug-induced interstitial lung disease treatment

Journal

Current medical science
ISSN: 2523-899X
Titre abrégé: Curr Med Sci
Pays: China
ID NLM: 101729993

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 14 10 2022
accepted: 06 12 2022
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 8 3 2023
Statut: ppublish

Résumé

Drug-induced interstitial lung disease (DILD) is the most common pulmonary adverse event of anticancer drugs. In recent years, the incidence of anticancer DILD has gradually increased with the rapid development of novel anticancer agents. Due to the diverse clinical manifestations and the lack of specific diagnostic criteria, DILD is difficult to diagnose and may even become fatal if not treated properly. Herein, a multidisciplinary group of experts from oncology, respiratory, imaging, pharmacology, pathology, and radiology departments in China has reached the "expert consensus on the diagnosis and treatment of anticancer DILD" after several rounds of a comprehensive investigation. This consensus aims to improve the awareness of clinicians and provide recommendations for the early screening, diagnosis, and treatment of anticancer DILD. This consensus also emphasizes the importance of multidisciplinary collaboration while managing DILD.

Identifiants

pubmed: 36867358
doi: 10.1007/s11596-022-2693-2
pii: 10.1007/s11596-022-2693-2
pmc: PMC9982790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Informations de copyright

© 2023. The Author(s).

Références

Am J Physiol Lung Cell Mol Physiol. 2012 Jan 15;302(2):L193-205
pubmed: 22003091
J Natl Compr Canc Netw. 2022 Apr;20(4):387-405
pubmed: 35390769
N Engl J Med. 2014 May 29;370(22):2083-92
pubmed: 24836312
Int J Cancer. 2016 May 15;138(10):2312-21
pubmed: 26452336
Toxicol Lett. 2000 Mar 15;112-113:171-6
pubmed: 10720728
Support Care Cancer. 2020 Dec;28(12):6145-6157
pubmed: 32880733
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Oct 12;40(10):721-723
pubmed: 29050123
Crit Care. 2017 Aug 25;21(1):228
pubmed: 28841896
N Engl J Med. 2014 May 29;370(22):2071-82
pubmed: 24836310
Acta Radiol. 2020 Feb;61(2):184-194
pubmed: 31226879
Respir Investig. 2013 Dec;51(4):260-77
pubmed: 24238235
Open Respir Med J. 2012;6:63-74
pubmed: 22896776
Br J Radiol. 2017 Mar;90(1071):20160723
pubmed: 28106480
Respir Res. 2012 May 31;13:39
pubmed: 22651223
Chest. 2021 Mar;159(3):1107-1125
pubmed: 33450293
Cancer Manag Res. 2017 Jun 14;9:207-213
pubmed: 28652812
J Clin Med. 2018 Oct 15;7(10):
pubmed: 30326612
Toxicol Pathol. 2009 Dec;37(7):997-1005
pubmed: 20008549
Chest. 2017 Aug;152(2):271-281
pubmed: 28499515
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
J Clin Oncol. 2007 May 20;25(15):1960-6
pubmed: 17452677
Br J Radiol. 2013 Jul;86(1027):20120614
pubmed: 23659926
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
Clin Imaging. 2018 Sep - Oct;51:332-336
pubmed: 29960266
BMJ. 2020 Apr 6;369:m736
pubmed: 32253223
Eur Respir J. 2017 Aug 10;50(2):
pubmed: 28798088
Rev Med Liege. 2018 May;73(5-6):319-325
pubmed: 29926573
Nat Rev Dis Primers. 2020 Aug 6;6(1):65
pubmed: 32764620
N Engl J Med. 2022 Mar 24;386(12):1143-1154
pubmed: 35320644
J Emerg Med. 1983;1(2):165-7
pubmed: 6389671
Eur J Radiol. 2014 Aug;83(8):1461-9
pubmed: 24853247
J Clin Oncol. 2013 Sep 20;31(27):3327-34
pubmed: 23816960
Am Fam Physician. 2015 Feb 15;91(4):250-6
pubmed: 25955626
Clin Chest Med. 2004 Mar;25(1):1-14
pubmed: 15062592
Oncologist. 2021 Apr;26(4):e580-e587
pubmed: 33191524
Dis Mon. 1994 May;40(5):253-310
pubmed: 8174459
Am J Respir Crit Care Med. 2019 Jul 15;200(2):168-174
pubmed: 31150266
Lancet Oncol. 2014 Feb;15(2):213-22
pubmed: 24439929
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
pubmed: 11790668
Radiographics. 2019 Nov-Dec;39(7):1923-1937
pubmed: 31584861
Ann Am Thorac Soc. 2014 Aug;11 Suppl 4:S189-92
pubmed: 25148424
Expert Rev Anticancer Ther. 2018 Oct;18(10):1041-1057
pubmed: 29996062
Hum Pathol. 2018 Feb;72:1-17
pubmed: 29180253
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Expert Rev Anticancer Ther. 2013 Aug;13(8):997-1006
pubmed: 23984900
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Radiographics. 2013 Nov-Dec;33(7):1951-75
pubmed: 24224590
Ann Oncol. 2017 Oct 01;28(10):2377-2385
pubmed: 28945858
Cancer. 2018 Jan 15;124(2):271-277
pubmed: 28960263
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
J Clin Oncol. 2017 Mar;35(7):709-717
pubmed: 27646942
Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):137-43
pubmed: 11777631
Zhongguo Fei Ai Za Zhi. 2019 Feb 20;22(2):57-81
pubmed: 30827323
Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):154-160
pubmed: 30931360
Ann Oncol. 2017 Oct 01;28(10):2443-2450
pubmed: 28945850

Auteurs

Hua-Ping Dai (HP)

Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, 100029, China. daihuaping@ccmu.edu.cn.

Fei Ma (F)

Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 10021, China. drmafei@126.com.

Yan-Hong Ren (YH)

Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, 100029, China.

Shan-Shan Chen (SS)

Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 10021, China.

Yi-Qun Li (YQ)

Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 10021, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH